PACIFIC LEGEND (08547) issues a profit warning, expecting an annual loss attributable to shareholders of not less than HKD 49 million.
PACIFIC LEGEND (08547) announced that the Group expects the loss attributable to shareholders to significantly increase from approximately HK$5.2 million for the eighteen months ending June 30, 2025, to not less than approximately HK$49 million for the year ending June 30, 2026.
PACIFIC LEGEND (08547) announced that the Group expects the loss attributable to shareholders to significantly increase from HK$5.2 million for the eighteen months ended June 30, 2025, to approximately no less than HK$49 million for the year ending June 30, 2026.
The Group's performance for the year ending June 30, 2026, is expected to decline compared to the eighteen-month period ended June 30, 2025, primarily due to (i) the loss of a major client (a well-known property developer in Hong Kong), resulting in a substantial decrease in revenue; and (ii) delays in the commencement of a major project in the United Arab Emirates, leading to a reduction in recognized revenue for the year ending June 30, 2026.
The Board is closely monitoring the current situation and will seek further measures to mitigate losses.
Related Articles

WEIGAO GROUP (01066) spent HKD 65,000 on September 8 to repurchase 20,000 shares.

TEDA BIOMEDICAL (08189) subsidiary Yishuzhengcheng has signed a strategic cooperation agreement with Zhongtong Construction Design Institute.

ASIA ALLIED INF (00711) repurchased 240,000 shares at a cost of HK$103,200 on September 8.
WEIGAO GROUP (01066) spent HKD 65,000 on September 8 to repurchase 20,000 shares.

TEDA BIOMEDICAL (08189) subsidiary Yishuzhengcheng has signed a strategic cooperation agreement with Zhongtong Construction Design Institute.

ASIA ALLIED INF (00711) repurchased 240,000 shares at a cost of HK$103,200 on September 8.

RECOMMEND





